FDA Announces Warning for Some Birth Control Pills

.

FDA Announces Warning for Some Birth Control Pills

As per recent reports, it has been revealed that FDA has asked the birth pill manufacturers to carry a warning if their drug carries the hormone drospirenone. The warning should contain the message that person taking the pill can develop fatal blood clots.

Some of the many birth control drugs, which will need to carry the warning, are Beyaz, Safyral, Yasmin, and Yaz and Gianvi, Loryna, Ocella and Zarah. The FDA said that the drugs, which carry the hormone, increase the risk of developing blood clots by three times. However, no such risk is present in other drugs, which do not carry the hormone drospirenone.

It has been found that changes in the labeling were proposed at an FDA advisory committee in December 2011, but it is now that the proposal has been passed. It is, however, recommended that women should consult their respective GPs before they start taking any birth control pill.

"Women who use birth control pills with drospirenone (like Yaz) may have a higher risk of getting a blood clot”, read the US Food and Drug Administration website.

Experts were of the view that drospirenone is nothing but a synthetic version of progesterone, a female sex hormone.


Latest News

DoubleLine Capital Sold Off All its European Equities Holdings following a Huge
Qualcomm Files Complaint against Meizu with Beijing Authorities over Intellectua
Barnes & Noble Broadening its Business Model Venturing into a Beer and Wine Stor
Will Result of the Brexit Vote Reflect in the U.S. Presidential Elections? A Que
Report Shows Large Number of Americans still Prefer Receiving Credit Card Statem
U.S. Big Banks Pass Annual Stress Test
Viacom’s Board will Remain as it is for the Time being, Judge Sets Hearing for J
Crude Stockpiles Drop in the U. S
A New Study Highlights that U. S. Expected to Spend $2.6 Trillion Less than Esti
SolarCity Shares Soar with Tesla's Bid for the Company
The Leave as well as Remain Camps Gathers Pace in Brexit
Oil’s Advance Halts as Market Awaits U.S Stock Pile Data and Brexit Poll